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Abstract
Objective: Recent genome-wide association studies identified novel candidate genes for fasting and 2 h blood glucose and
insulin levels in adults. We investigated the role of four of these loci (ADCY5, GIPR, GCKR and VPS13C) in early impairment of
glucose and insulin metabolism in children.
Research Design and Methods: We genotyped four variants (rs2877716; rs1260326; rs10423928; rs17271305) in 638
Caucasian children with detailed metabolic testing including an oGTT and assessed associations with measures of glucose
and insulin metabolism (including fasting blood glucose, insulin levels and insulin sensitivity/secretion indices) by linear
regression analyses adjusted for age, sex, BMI-SDS and pubertal stage.
Results: The major allele (C) of rs2877716 (ADCY5) was nominally associated with decreased fasting plasma insulin (P=0.008),
peak insulin (P=0.009) and increased QUICKI (P=0.016) and Matsuda insulin sensitivity index (P=0.013). rs17271305 (VPS13C)wa s
nominally associated with 2 h blood glucose (P=0.009), but not with any of the insulin or insulin sensitivity parameters. We found
no association of the GIPR and GCKR variants with parameters of glucose and insulin metabolism. None of the variants correlated
with anthropometric traits such as height, WHR or BMI-SDS, which excluded potential underlying associations with obesity.
Conclusions: Our data on obese children indicate effects of genetic variation within ADCY5 in early impairment of insulin
metabolism and VPS13C in early impairment of blood glucose homeostasis.
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Introduction
Although obesity is the most important risk factor for disorders of
glucose metabolism such as type 2 diabetes (T2D), the risk for those
metabolic disorders is modified by an individual’s genetic pre-
disposition. Recent genome wide association studies (GWAS) have
identified several genetic loci associated with fasting blood glucose
(FBG), 2 h blood glucose (BG) and insulin secretion in adults [1,2].
In a meta analysis of GWAS on 2 h BG after an oral glucose
challenge, three novel loci (GIPR, ADCY5 and VPS13C) have
emerged to be of highest significance and potential importance in
adults (2). Of the previously known genes associated with type 2
diabetes (T2D), variants in GCKR and TCF7L2 were confirmed to
be associated with 2 h BG [2]. However, most of these and sub-
sequent replication studies were performed in adults. Since children
are much less biased by comorbidities and their medication, and
considering that the exposure to environmental factors, particularly
obesity, is much shorter, they are an attractive population for
identifying primary genetic determinants controlling complex
polygenic traits.
We previously showed that diabetes susceptibility variants
in TCF7L2 were associated with early impairment of glucose
tolerance in children before they develop overt diabetes [3]. Here,
we aimed to elucidate the role of four new recently identified loci
(GCKR, GIPR, ADCY5 and VPS13C) in early impairment of glucose
and insulin metabolism by investigating their effects in a cohort of
obese Caucasian children.
Methods
Subjects
Ethics Statement. Written informed consent was obtained
from all guardians and children older 12 years. The study was
approved by the ethical committee of the University of Leipzig.
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e22101Cohort design. We recruited 571 Caucasian children and
adolescents from our obesity clinic (Leipzig, Germany) with a
BMI$1.23 SDS (standard deviation score). This cohort included
61 overweight (1.88 SDS$BMI$1.23 SDS) subjects. In addi-
tion, we included 67 healthy lean controls from our Leipzig
Atherobesity Childhood cohort [4]. We excluded participants with
antidiabetic medications (metformin) prior to analysis. Height was
measured to the nearest of 0.1 cm and weight to the nearest of
0.1 kg using a digital scale. Body mass index (BMI) data were
standardized to age and sex of the children applying German
reference data [5], and is given as BMI standard deviation score
(SDS). Demographic characteristics of the study cohort are given
in Table 1. Blood lipids, glucose and insulin were measured by a
certified laboratory applying standard clinical biochemistry
methods.
We performed a comprehensive metabolic work-up, including
lipid profiles, an oral glucose tolerance test (oGTT) and blood
pressure measurements in all children. For oGTT, blood samples
were collected at 0, 30, 60, 90 and 120 minutes after the glucose
load of 1.75 g per kg body weight (maximum of 75 g glucose). We
calculated several insulin sensitivity and resistance indices to assess
glucose homeostasis in children (precise equations are given in
Method S1). The prevalence of impaired FBG was 9.0% and the
prevalence of impaired glucose tolerance was 15.3% in our
sample.
Genotyping. Four variants (rs2877716, rs1260326, rs10423928,
rs17271305) were genotyped using TaqMan allelic discrimination
assays (Applied Biosystems, Inc., Foster City, CA) on ABI PRISM
7500 sequence detector (Applied Biosystems). Genotyping repro-
ducibility was assessed with a random 5% selection of the samples,
which were re-genotyped for all variants and we obtained 100%
concordance.
Statistical analyses. We performed logarithmic trans-
formation with logarithmus naturalis (ln) for measures that were
not normally distributed. To test for associations of genetic
variants with quantitative traits of metabolic and anthropometric
characteristics we applied generalized linear regression models
under the additive mode of inheritance adjusted for age, sex,
pubertal stage and BMI SDS. Pubertal stage is clinically assessed
by Tanner stage ranging from PH1 (=prepubertal) to PH5
(=adolescent, puberty completed). Hence, we regarded the PH as
an ordinal variable.
A P-value,0.05 was considered to provide nominal evidence for
association. Considering four SNPs and two traits (glucose, insulin)
being analysed, a P-value,0.00625 would indicate significance
after Bonferroni corrections for multiple testing. Power calcula-
tions for BMI SDS and metabolic traits for all SNPs are given in
Supplementary Table S1.
Statistical analyses were performed using the SPSS software
package (version 18.0) (SPSS, Inc., Chicago, IL).
Results
We evaluated associations of the four variants (minor allele
frequency) rs2877716 (0.21), rs1260326 (0.40), rs10423928 (0.22),
rs17271305 (0.37) in 638 children. Genotyped allelic frequencies
were consistent with Hardy-Weinberg equilibrium for all variants.
Data on metabolic traits stratified by genotypes are given in
Table 2.
Association of genotypes with parameters of obesity
We did not observe a significant association of any of the
variants with BMI SDS or other surrogate markers of obesity such
as skinfold or WHR (all P.0.2) (Table 3). Also, there was no
association with birth weight. Results were concordant irrespective
of the genetic model (additive/dominant) applied.
Association of genotypes with insulin and glucose traits
The C-allele in rs2877716 (ADCY5) was nominally associated
with parameters of insulin secretion and insulin resistance, such as
a lower fasting plasma insulin, peak insulin (Fig. 1A), HOMA-B
and a higher QUICKI and ISI (Fig. 1C), but showed no impact on
blood glucose parameters (Fig. 1B) (Table 1). The associations
were preserved after additional adjustment for BMI-SDS and
hence independent of obesity (Table 3).
The A-allele in rs17271305 (VPS13C) was significantly associ-
ated with a lower 2 h BG (Fig. 1B). Again, after adjustment for
BMI SDS, the association became weaker but remained nominal
(Table 3).
Plotting the genotype stratified response to oral glucose
illustrated the association of rs2877716 (ADCY5) with insulin
response, while for rs17271305 (VPS13C) the glucose response was
different according to genotype (Fig. 1D+E).
The variants in GIPR and GCKR did not show any significant
association with insulin and glucose or with insulin resistance/
sensitivity indices (Table 3).
We did not find any significant relationships between any of the
variants and cholesterol levels, liver enzymes or serum leptin
concentrations.
Discussion
In this study we show a nominal association of rs2877716
(ADCY5) with insulin secretion and of rs17271305 (VPS13C) with
2 h BG in children. Other variants previously associated with
glucose homeostasis in adults were, however, not associated with
parameters of glucose or insulin metabolism in children.
To our knowledge these results are the first data shown for
children. Our finding in a cohort with a mean age of 11.5 years
and hence shorter exposure to obesity and other adverse (life style)
factors, supports a role of ADCY5 in the pathophysiology of insulin
resistance, independent of obesity. The biological function of
adenylate cyclase 5 is diverse. It is a member of the adenylate
cyclase family, which consists of twelve domain transmembrane
proteins that catalyzes the conversion of ATP to cyclic AMP, the
second messenger for G protein coupled receptors. The ADCY
isoform 5 has been described to mediate renin release [6],
influence heart rate [7] and interact with dopamine homeostasis in
the central nervous system [8], hence particularly affecting
endocrine/metabolic and cardiovascular signaling. Adjusting
analyses for BMI SDS somewhat diminished the magnitude of
the effect; although it was still significant. Considering the strong
impact of obesity on insulin metabolism, an additional contribu-
tion of BMI to hyperinsulinemia may be possible. It is well known
that children go through a phase of (physiological) insulin
Table 1. Demographic characteristics of study population.
Variable Mean±SD
n (girls/boys) 638 (333/305)
Age (years) 11.563.6
BMI (kg/m
2)2 8 . 0 66.7
BMI SDS 2.2661.10
WHR 0.8760.08
PH 2.6561.74
doi:10.1371/journal.pone.0022101.t001
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PLoS ONE | www.plosone.org 3 July 2011 | Volume 6 | Issue 7 | e22101resistance during mid-puberty [9]. We have, therefore, adjusted
our analyses for pubertal stage in addition to age and the observed
associations are hence unbiased by this phenomenon.
Interestingly, variants in ADCY5 were also found to be
associated with birth weight and fetal growth [10]. Since lower
birth weight itself is a risk factor for type 2 diabetes [11], an
interaction of rs2877716 with birth weight and glucose homeo-
stasis could be hypothesized. We did, however, not observe any
relationship between rs2877716 genotype and birth weight or with
current BMI or other obesity measures in our cohort. Therefore,
the association of rs2877716 with insulin secretion does not appear
to be secondary to an underlying association of rs2877716 with
birth weight or with obesity. Also, the analysis of the association of
rs2877716 with insulin secretion parameters in the lean subcohort
did reveal significant association, although we are aware of the
limited sample size not allowing conclusive evidence from this
subcohort.
Our data show that presence of the C-allele in rs2877716 results
in lower glucose stimulated plasma insulin and consequently on
insulin derived indices. This does, however, not lead to higher
blood glucose implicating that glucose homeostasis in these
children still being preserved. We can, however, not explain the
U-shaped distribution of phenotypes for the HOMA-B. However,
the other parameters (e.g. HOMA-IR, insulin levels) show
increasing values with the number of minor (T-) alleles indicating
that the C-allele is associated with decreased peak insulin and
better insulin sensitivity. In previous studies in adults the effects of
rs2877716 was consistent with our data. Dupuis et al. showed the
same effect for rs11708067, which is in 95% Linkage disequilib-
rium with rs2877716, and described a nominal association of the
major allele with a lower fasting insulin and with higher 2 h BG [1].
The sequence of events of obesity with subsequent insulin
resistance and consequently hyperinsulinemia is understood in that
increased post-challenge glucose levels result from the deviation of
the hyperbolic relationship between insulin sensitivity and insulin
plasma levels and is hence a sign of decompensation of b-cell
function [12,13]. While there is a gradual but continuous decline
in b-cell function, glucose levels rise relatively late in this
pathologic process. Hence, considering that children represent
an earlier stage of pathology, it is not entirely unexpected, that we
do see a change in insulin levels, while glucose levels are still
relatively preserved. Hence, the association of the ADCY5 SNP
may still be related to the complex glucose-insulin-pathophysiol-
ogy, but not exclusively to glucose levels (as concluded from adult
studies).
Ingelsson et al. performed a detailed characterization with
discrimination of insulin processing, secretion and sensitivity [14].
Their results indicate that GIPR is associated with a lower insulin
secretion (represented by insulinogenic index), GCKR with a
reduced insulin sensitivity (represented by Stumvoll, Matsuda and
Belfiore indices), while VPS13C was only modestly associated with
higher proinsulin levels and ADCY5 did not show any obvious
effect on insulin sensitivity or secretion in adults.
A common assumption is that children, unlike adults, are less
influenced by prolonged exposure to environmental factors and
obesity related comorbidities and therefore allow discriminating
primary genetic determinants assumed to effect complex polygenic
diseases like obesity. Nevertheless, the variant-effect may manifest
in later stages of life, potentially additionally modified by gene-
environment interactions [15], or may be detectable only with
advanced stages of disease, which are less prevalent in children.
In consequence, obese children present with earlier stages of
Table 3. Effect sizes and P values for metabolic parameters according to genotype.
rs2877716 (ADCY5) rs1260326 (GCKR) rs10423928 (GIPR) rs17271305 (VPS13C)
Beta
1 P
1 Beta
2 P
2 Beta
1 P
1 Beta
2 P
2 Beta
1 P
1 Beta
2 P
2 Beta
1 P
1 Beta
2 P
2
BMI SDS 20.1 0.162 20.02 0.701 20.08 0.238 20.03 0.681
FBG ,0.01 0.932 ,0.01 0.963 0.02 0.443 0.02 0.426 0.03 0.369 0.03 0.314 ,0.01 0.944 ,0.01 0.928
BG (2 h) 0.06 0.400 0.08 0.245 0.03 0.662 0.03 0.588 20.01 0.897 0.01 0.903 20.16 0.009 20.15 0.009
BG AUC 5.16 0.554 7 0.419 24.41 0.562 24.27 0.570 6.9 0.428 8.42 0.329 28.35 0.269 28.26 0.270
FPI
a 20.1 0.008 20.08 0.024 20.01 0.664 20.01 0.769 20.05 0.246 20.03 0.384 0.01 0.667 0.02 0.527
Insulin Peak
a 20.11 0.009 20.09 0.023 ,0.01 0.980 0.01 0.884 0.02 0.710 0.03 0.466 0.01 0.770 0.01 0.691
Insulin AUC
a 20.09 0.034 20.07 0.075 20.01 0.709 20.01 0.742 0.03 0.471 0.05 0.255 0.02 0.551 0.03 0.452
HOMA-Ir
a 20.1 0.015 20.08 0.043 20.01 0.775 20.01 0.864 20.04 0.352 20.02 0.510 0.02 0.653 0.02 0.538
HOMA-B
a 20.14 0.004 20.12 0.010 20.04 0.324 20.03 0.355 20.08 0.098 20.07 0.126 0.02 0.552 0.03 0.473
QUICKI
a 0.02 0.016 0.01 0.045 ,0.01 0.766 ,0.01 0.854 0.01 0.342 ,0.01 0.497 ,0.01 0.693 ,0.01 0.575
ISI
a 0.1 0.013 0.08 0.035 0.02 0.633 0.01 0.701 0.02 0.651 0.01 0.871 20.01 0.860 20.01 0.757
Belfiore
a 0.07 0.081 0.06 0.164 0.04 0.320 0.03 0.357 20.03 0.540 20.04 0.333 20.01 0.718 20.02 0.629
Gutt
a 20.01 0.641 20.02 0.386 20.01 0.548 20.01 0.463 20.01 0.619 20.02 0.434 20.01 0.641 20.01 0.545
Stumvoll ,0.01 0.746 ,0.01 0.459 ,0.01 0.931 ,0.01 0.927 ,0.01 0.651 ,0.01 0.982 0.01 0.324 0.01 0.355
IGI
a 20.1 0.050 20.08 0.093 ,0.01 0.956 ,0.01 0.958 0.03 0.484 0.05 0.334 20.03 0.535 20.03 0.542
Ratio AUCBG/AUCInsulin
a 20.08 0.043 20.07 0.086 20.01 0.820 20.01 0.815 0.03 0.456 0.04 0.280 0.03 0.390 0.03 0.320
All data is adjusted to age, sex and pubertal state. Beta is non-standardized per-allele beta (SE) in the additive model and refers to the major allele. FBG: Fasting blood
glucose (mmol/l); BG: blood glucose; FPI: fasting plasma insulin (pmol/L); AUC: Area under the curve; For a detailed description of the Insulin resistance and –sensitivity
indices see Method S1.
1adjusted for age, sex and pubertal stage;
2adjusted for age, sex, pubertal stage and BMI SDS;
afor non-normally distributed variables, data were log-transformed.
doi:10.1371/journal.pone.0022101.t003
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the deterioration of blood glucose allostasis [16]. Nevertheless,
considering our observed associations with insulin parameters and
that insulin parameters are the first to be affected in obese
children, one may conclude that rs2877716 is affecting insulin
secretion and/or resistance at an early stage.
The variant in the VPS13C gene showed a nominal association
with blood glucose, but unexpectedly no association with insulin
secretion or indices of insulin resistance. The family of VPS13C
plays a role in transport of membrane proteins between trans-
Golgi network and the prevacuolar compartment [17] and is
highly expressed in beta cells [2]. However, the precise function of
VPS13C is unknown. Saxena et al. found rs17271305 to be
associated with 2 h BG and lower 2 h insulin, but not with T2D.
We were able to replicate the association with 2 h BG already in
children. Also similar to adults, the insulin response to oral glucose
was not different between carriers of the risk allele and wild types.
Finally, we did not detect any effect of variants in GIPR or
GCKR with glucose metabolism in this pediatric study. Again, we
may speculate that this lack of significance is due to the less
prevalent overt phenotype in children, or that the effect of these
variants is not as strong as other genes.
We are aware that our study has several limitations. Even
though we did achieve nominal associations for the SNPs in
ADCY5 and VPS13C, when each SNP and trait was considered
separately, the association would not withstand correction for
Bonferroni multiple testing with a P value of 0.00625 as a
threshold of statistical significance. This is most likely due to the
small sample size. Given the observed allele frequencies for the
respective SNPs, we achieved 80% statistical power to detect effect
sizes ranging from 0.077 to 0.09 for FBG and from 0.16 to
0.19 mmol/L for 2 h BG in the additive model. We may,
therefore, have missed associations for smaller effects. In the paper
by Saxena et al. [2], the observed effect size was 0.09 mmol/L per
allele for 2 h BG for ADCY5, which is indeed beyond the limit that
we were able to detect in our cohort, and which may partially
explain whyweseenominal positive associationsforonlyfew insulin
and glucose determinants. Nevertheless, considering the observed
associations with insulin parameters and that insulin parameters are
the first to be affected in obese children, one may conclude that this
SNP is affecting insulin secretion and/or resistance at an early stage.
It is also noteworthy that consistent with the discovery GWAS [1,2]
suggesting additive mode of inheritance for the allele affects, we
applied the same model in our analyses despite the small number of
homozygous subjects for the minor alleles e.g. at ADCY5 and GIPR.
In summary, we provide evidence that in children genetic
variations within ADCY5 and VPS13C contribute to early impair-
ment of insulin metabolism and early impairment of blood glucose
homeostasis, respectively.
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Figure 1. Association of rs2877716 (ADCY5) and rs17271305 (VPS13C) risk alleles with metabolic parameters. Peak insulin (A), 2 h blood
glucose (B) and Matsuda insulin sensitivity index (C) are given for respective genotypes of rs2877716 (left) and rs17271305 (right). Dynamic course of
insulin (D) and blood glucose (E) are given for carriers of the risk allele and wild types as indicated. The effects determined by oral glucose tolerance
test were evaluated using generalized linear regression models applying the additive model of inheritance as indicated. The analysis was adjusted for
age, sex and pubertal stage. Data are shown as mean6SEM.
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